Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery

Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery

Martin Schillinger, Schila Sabeti, Christian Loewe et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Medicine, Surgery, Interventional Cardiology +14

Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg

Gunnar Tepe, Thomas Zeller, Thomas Albrecht et al. · New England Journal of Medicine · 2008 · 798 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Inhibition of Restenosis in Femoropopliteal Arteries

Michael Werk, Sönke Langner, Bianka Reinkensmeier et al. · Circulation · 2008 · 507 citations · Full text

Medicine, Cardiology, Surgery +17

Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting

Martin Schillinger, Schila Sabeti, Petra Dick et al. · Circulation · 2007 · 499 citations · Full text

Medicine, Surgery, Interventional Cardiology +13

The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization

Dierk Scheinert, Stephan H. Duda, Thomas Zeller et al. · JACC: Cardiovascular Interventions · 2014 · 395 citations

Medicine, Surgery, Interventional Cardiology +12